Cartesian Therapeutics, Inc. (RNAC)
7.85
-0.05
(-0.63%)
USD |
NASDAQ |
Dec 10, 11:23
Cartesian Therapeutics EPS Diluted (Quarterly): -1.381 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2638 |
| Cabaletta Bio, Inc. | -0.4387 |
| Arcellx, Inc. | -0.9858 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.90M |
| Revenue (Quarterly) | 0.452M |
| Total Expenses (Quarterly) | 36.35M |
| Enterprise Value | 74.65M |
| Gross Profit Margin (Quarterly) | -97.65% |
| Profit Margin (Quarterly) | -7.94K% |
| Earnings Yield | -32.99% |
| Normalized Earnings Yield | -36.34 |